Xenon Pharmaceuticals XENE
NASDAQ XENE
$37.02 -0.23 (-0.62%)
As of: Sep 30, 2026 · 1:43 PM EDT

Xenon Pharmaceuticals Inc. (XENE) Net Margin (2013 - 2025)

Updated

Xenon Pharmaceuticals (XENE) recorded Net Margin of -4612.13% in FY2025.

Analysis

Xenon Pharmaceuticals Inc. (XENE) Net Margin (2013 - 2025) Analysis & Trends

Starting with FY2012, Xenon Pharmaceuticals' Net Margin history includes 11 years.

  • Annual Net Margin has a five-year change of -4525.04 percentage points (FY2020 to FY2025).
  • The FY2025 figure is the highest annual Net Margin since FY2022.
  • Per Business Quant data, XENE's Net Margin was -1324.32% in FY2022 (-906.21 pp) and -418.11% in FY2021 (-331.02 pp).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -867.29%
Sep 30, 2022 -28,143.94%
Jun 30, 2022 -5,813.06%
Mar 31, 2022 -220.98%
Dec 31, 2021 -671.05%
Sep 30, 2021 -185.66%
Jun 30, 2021 -973.31%
Mar 31, 2021 -352.02%
Dec 31, 2020 -232.49%
Sep 30, 2020 -131.29%
Jun 30, 2020 -1.27%
Mar 31, 2020 -102.60%
Dec 31, 2019 -329.05%
Sep 30, 2019 -243.86%
Dec 31, 2017 -50,406.25%
Sep 30, 2017 -2,932.58%
Jun 30, 2017 -49,200.00%
Mar 31, 2017 -46,981.25%
Dec 31, 2016 -1,596.81%
Sep 30, 2016 -1,867.80%
API Access

Xenon Pharmaceuticals Inc. Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=XENE&period=max&api_key=YOUR_API_KEY